Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 29, 2022

BUY
$230.71 - $256.74 $369,136 - $410,784
1,600 New
1,600 $389,000
Q1 2022

May 06, 2022

SELL
$219.27 - $242.57 $350,832 - $388,112
-1,600 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$198.88 - $227.6 $318,208 - $364,160
1,600 New
1,600 $360,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Coulter & Justus Financial Services, LLC Portfolio

Follow Coulter & Justus Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coulter & Justus Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coulter & Justus Financial Services, LLC with notifications on news.